Water-based nanoparticulate polymeric system for protein delivery: Permeability control and vaccine application

被引:28
作者
Prokop, A [1 ]
Kozlov, E
Newman, GW
Newman, MJ
机构
[1] Vanderbilt Univ, Dept Chem Engn, Nashville, TN 37235 USA
[2] Morehouse Sch Med, Atlanta, GA 30310 USA
[3] Epimmune Inc, San Diego, CA 92121 USA
关键词
nanoparticle; water-based; polymeric; antigen delivery; protein delivery; crosslinking; permeability control;
D O I
10.1002/bit.1200
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The idea of using polymeric nanoparticles as drug carriers is receiving an increasing amount of attention both in academia and industry, Nanoparticles have a number of potential applications in protein, drug and vaccine delivery, as well as gene therapy applications. In this article, we focus on this unique drug delivery technology as a method to control the release rate of substances, not only for protein delivery but also for delivering an experimental vaccine immunogen. Nanoparticles were assembled on the basis of ionic interaction between water-soluble polymers so that the resulting particles were stable in physiologic media. Among the typical polymers used to assemble nanoparticles, different polysaccharides, natural amines, and poly-amines were investigated. The entrapped substances tested included a protein and antigens. Poly-dextran aldehyde was incorporated into the particle core, to enable physiologic cross-linking as a method to control permeability. This resulted in long-term retention of substances that would otherwise rapidly leak out of the nanoparticles. Results of cross-linking experiments clearly demonstrated that the release rate could be substantially reduced, depending on the degree of cross-linking. For vaccine antigen delivery tests, we measured an antibody production after subcutaneous and oral administration. The data indicated that only the crosslinked antigen was immunogenic when the oral route of administration was used. The data presented in this article address primarily the utility of nanoparticulates for oral delivery of vaccine antigen. (C) 2002 Wiley Periodicals, Inc.
引用
收藏
页码:459 / 466
页数:8
相关论文
共 34 条
[1]  
[Anonymous], 1987, DRUG DELIVERY SYSTEM
[2]  
Calvo P, 1997, J APPL POLYM SCI, V63, P125, DOI 10.1002/(SICI)1097-4628(19970103)63:1<125::AID-APP13>3.0.CO
[3]  
2-4
[4]   In-vitro gastric stability of carrageenan [J].
Capron, I ;
Yvon, M ;
Muller, G .
FOOD HYDROCOLLOIDS, 1996, 10 (02) :239-244
[5]  
Cleland J L, 1995, Pharm Biotechnol, V6, P439
[6]  
Damge C, 1996, J ANAT, V189, P491
[7]  
Duncan Jacqueline D., 1996, P159, DOI 10.1016/B978-012410580-5/50013-3
[8]   BIODEGRADABLE MICROSPHERES AS A VACCINE DELIVERY SYSTEM [J].
ELDRIDGE, JH ;
STAAS, JK ;
MEULBROEK, JA ;
MCGHEE, JR ;
TICE, TR ;
GILLEY, RM .
MOLECULAR IMMUNOLOGY, 1991, 28 (03) :287-294
[9]   BIODEGRADABLE POLY(DL-LACTIDE-CO-GLYCOLIDE) MICROSPHERES [J].
ELDRIDGE, JH ;
STAAS, JK ;
TICE, TR ;
GILLEY, RM .
RESEARCH IN IMMUNOLOGY, 1992, 143 (05) :557-563
[10]  
FAGNANI R, 1990, CANCER RES, V50, P3638